My HPRA: Register

MEDISIP WITH DECONGESTANT POWDER FOR ORAL SOLUTION

500/12.2 Milligram Powder for Oral Solution

Actavis Group PTC ehfPA1380/160/001

Main Information

Trade NameMEDISIP WITH DECONGESTANT POWDER FOR ORAL SOLUTION
Active SubstancesPARACETAMOL
PHENYLEPHRINE HYDROCHLORIDE
Strength500/12.2 Milligram
Dosage FormPowder for Oral Solution
Licence HolderActavis Group PTC ehf
Licence NumberPA1380/160/001

Group Information

ATC CodeN02BE51 Analgesics and antipyretics

Status

Authorised/WithdrawnAuthorised
Licence Issued06/03/2015
Supply StatusSupply through pharmacies only
Dispensing StatusProduct not subject to medical prescription
Marketing StatusNot Marketed
Promotion StatusPromotion to the general public
Conditions of LicenceProduct Not Subject to Medical Prescription Supply through pharmacies only. Product not subject to medical prescription, supply through pharmacies only and promotion to the public subject to the following restrictions for phenylephrine base: maximum dose 12.2 mg, maximum daily dose 48.8 mg Retail sale through pharmacies only in packs containing not more than 24 individual unit dosage forms. Not more than two such packs should be supplied in the course of any one retail transaction unless a valid prescription exists.

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print

Summary of Product Characteristics

View More SPC Headings

Latest Changes to Medicine Info & SPC

View all available

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.